Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1979-06-22
1981-06-02
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
2603403, 2603405R, 424278, 424282, A61K 31335, A61K 3136, A61K 31165
Patent
active
042711932
ABSTRACT:
N.sub.1 -benzoyl-N.sub.2 -phenyl-1,3-diaminopropan-2-ols are disclosed which exhibit a stabilizing effect on the gastric mucosa and enhance the stability and resistance of the gastic mucosa against harmful effects caused by, e.g., excessive alcohol consumption or drugs. The compounds are useful in the prophylaxis and treatment of gastritis.
Further disclosed are pharmaceutical compositions which are effective in stabilizing the gastric mucosa and in the treatment and proplylaxis of gastritis and which comprise as a pharmacologically active ingredient N.sub.1 -benzoyl-N.sub.2 -phenyl-1,3-diaminopropan-2-ols, or a pharmaceutically acceptable acid addition salt thereof, and a pharmaceutically acceptable diluent. Further disclosed are processes for the preparation of the N.sub.1 -benzoyl-N.sub.2 -phenyl-1,3-diaminopropan-2-ols.
REFERENCES:
patent: 3998809 (1976-12-01), Milkowski et al.
Heinemann Henning
Hell Insa
Hempel Reinhard
Hueschens Rolf
Liepmann Hans
Kali-Chemie Pharma GmbH
Waddell Frederick E.
LandOfFree
N1-Benzoyl-N2-phenyldiaminopropanols and pharmaceutical composit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N1-Benzoyl-N2-phenyldiaminopropanols and pharmaceutical composit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N1-Benzoyl-N2-phenyldiaminopropanols and pharmaceutical composit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1865367